These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2352162)

  • 21. Intragastric behavior and absorption kinetics of a normal and "floating" modified-release capsule of isradipine under fasted and fed conditions.
    Mazer N; Abisch E; Gfeller JC; Laplanche R; Bauerfeind P; Cucala M; Lukachich M; Blum A
    J Pharm Sci; 1988 Aug; 77(8):647-57. PubMed ID: 2974884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An alprostadil analogue and human gastric secretion. A double-blind placebo-controlled study of the effects of a capsule and tablet formulation.
    Müller P; Dammann HG; Leucht U; Simon B
    Arzneimittelforschung; 1989 Jul; 39(7):809-11. PubMed ID: 2783184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of food intake on the gastric emptying of gastric juice-resistant tablets and capsules].
    Ewe K; Press AG; Oestreicher M
    Dtsch Med Wochenschr; 1992 Feb; 117(8):287-90. PubMed ID: 1537265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique.
    Grimm M; Ball K; Scholz E; Schneider F; Sivert A; Benameur H; Kromrey ML; Kühn JP; Weitschies W
    Eur J Pharm Sci; 2019 Mar; 129():163-172. PubMed ID: 30639530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enteric-coated pellets: theoretical analysis of effect of dispersion in the stomach on blood level profiles.
    Story MJ
    J Pharm Sci; 1977 Oct; 66(10):1495-6. PubMed ID: 925915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoscopic evaluation of the gastro-duodenal tolerance of short-term analgesic treatment with 25 mg diclofenac-K liquid capsules.
    Hawkey C; Burnett I; Gold MS; Garsed K; Stevenson D; Mannath J; Norman A; Shepherd V; Subramanian V; Johnston RD; Brown M
    Aliment Pharmacol Ther; 2012 Apr; 35(7):819-27. PubMed ID: 22372517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upper gastrointestinal lesions after potassium chloride supplements: a controlled clinical trial.
    McMahon FG; Ryan JR; Akdamar K; Ertan A
    Lancet; 1982 Nov; 2(8307):1059-61. PubMed ID: 6127542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Formulation on the Pharmacokinetics of Dutasteride: Results from Two Phase I Studies.
    Fossler M; Zhu J; Roehrborn C; McAleese P; Manyak M
    Clin Drug Investig; 2016 Sep; 36(9):763-767. PubMed ID: 27356530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
    Henney HR; Shah J
    Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
    Shah J; Wesnes KA; Kovelesky RA; Henney HR
    Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A gastroscopic and pharmacological study of the disintegration time and absorption of pivampicillin capsules and tablets.
    Hey H; Matzen P; Andersen JT; Didriksen E; Nielsen B
    Br J Clin Pharmacol; 1979 Sep; 8(3):237-42. PubMed ID: 497090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diclofenac potassium 25 mg liquid capsules: earlier and higher exposure to diclofenac. A fasted, single-dose, comparative bioavailability study vs. diclofenac potassium 2 x 12.5 mg tablets.
    Armogida M; Gold M
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):445-51. PubMed ID: 22677306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mass variation tests for coating tablets and hard capsules: rational application of mass variation tests.
    Katori N; Aoyagi N; Kojima S
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1176-80. PubMed ID: 12237532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioequivalence of zonisamide orally dispersible tablet and immediate-release capsule formulations: results from two open-label, randomized-sequence, single-dose, two-period, two-treatment crossover studies in healthy male volunteers.
    Maanen Rv; Bentley D
    Clin Ther; 2009 Jun; 31(6):1244-55. PubMed ID: 19695391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of formulation on oesophageal transit.
    Channer KS; Virjee JP
    J Pharm Pharmacol; 1985 Feb; 37(2):126-9. PubMed ID: 2858546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of in-vivo dispersion and gastric emptying on glibenclamide absorption from a novel, rapidly dissolving capsule formulation.
    Ganley JA; McEwen J; Calvert RT; Barker MC
    J Pharm Pharmacol; 1984 Nov; 36(11):734-9. PubMed ID: 6150975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Setipiprant, a selective oral antagonist of human CRTH2: relative bioavailability of a capsule and a tablet formulation in healthy female and male subjects.
    Baldoni D; Mackie A; Gutierrez M; Theodor R; Dingemanse J
    Clin Ther; 2013 Nov; 35(11):1842-8. PubMed ID: 24095247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.